StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $386 at Needham & Company
October 21, 2021 6:26 AM
Needham & Company analyst Ami Fadia lowered the price target on Biogen (NASDAQ: BIIB) to $386.00 (from $398.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $340 at Guggenheim
October 25, 2021 4:25 PM
Biogen (BIIB) PT Lowered to $295 at RBC Capital
October 21, 2021 6:06 AM
Biogen (BIIB) PT Lowered to $325 at BofA Securities
October 21, 2021 5:41 AM
Biogen (BIIB) PT Lowered to $440 at Morgan Stanley
October 21, 2021 4:37 AM
Biogen (BIIB) PT Lowered to $390 at Oppenheimer
October 20, 2021 6:05 PM
Biogen (BIIB) PT Lowered to $375 at Cowen
October 20, 2021 5:59 PM
Form 10-Q BIOGEN INC. For: Sep 30
October 20, 2021 4:21 PM
Biogen (BIIB) PT Lowered to $261 at Wedbush
October 20, 2021 1:42 PM
